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Adenoviral infection induces nucleoplasmic redistribution of a nucleolar nucleophosmin 1/NPM1/
B23.1. NPM1 is preferentially localized in the nucleoli of normal cells, whereas it is also present at the
nuclear matrix in cancer cells. However, the biological roles of NPM1 during infection are unknown.
Here, by analyzing a pV-deletion mutant, Ad5-dV/TSB, we demonstrate that pV promotes the NPM1
translocation from the nucleoli to the nucleoplasm in normal cells, and the NPM1 translocation is
correlated with adenoviral replication. Lack of pV causes a dramatic reduction of adenoviral replication
in normal cells, but not cancer cells, and Ad5-dV/TSB was defective in viral assembly in normal cells.
NPM1 knockdown inhibits adenoviral replication, suggesting an involvement of NPM1 in adenoviral
biology. Further, we show that NPM1 interacts with empty adenovirus particles which are an
intermediate during virion maturation by immunoelectron microscopy. Collectively, these data
implicate that pV participates in a process of viral assembly through NPM1.
& 2012 Elsevier Inc. All rights reserved.Introduction
Human adenoviruses are a member of Mastadenovirus, and a
non-enveloped, icosahedral virus containing a double-stranded
DNA genome (Davison et al., 2003), and contain a few genus-
speciﬁc genes missing in the other three viral taxons. One of the
genes is a minor core protein V (pV) (Davison et al., 2003), and an
adenovirus virion contains approximately 157 copies of pV (van
Oostrum and Burnett, 1985). Protein V is speculated to function as
a bridge between the core and the capsid proteins (Chatterjee
et al., 1985; Matthews and Russell, 1998; Vayda et al., 1983) andll rights reserved.
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mic DNA (Anderson et al., 1989; Chatterjee et al., 1986; Lehmberg
et al., 1999). Initially, pV localizes in the nucleoli during infection,
then translocates from the nucleoli to the nucleoplasm as the
infection progresses and is incorporated in infectious viral parti-
cles (Ugai et al., 2010). On the other hand, the deletion of the pV
gene from the human adenovirus type 5 (Ad5) genome reveals
that pV is not essential for adenoviral replication and assembly of
infectious viral particles in cancerous cells (Ugai et al., 2007).
Interestingly, transient expression of pV induces the redistribu-
tion of nucleophosmin 1/NPM1/B23.1 from the nucleoli to the
nucleoplasm and the cytoplasm in vitro (Matthews, 2001). Also,
adenoviral infection induces NPM1 nucleolar delocalization
(Walton et al., 1989).
NPM1 is an abundant nucleolar phosphoprotein (Grisendi
et al., 2006), but is expressed at fairly modest levels in human
normal cells (Nozawa et al., 1996). In contrast to the expression of
NPM1 in human normal cells, NPM1 is isolated as one of the most
abundant nuclear matrix proteins in cancer cells (Mattern et al.,
1996; Zink et al., 2004), and detected in the nucleoplasm as well
as in the nucleoli of tumors (Subong et al., 1999) and over-
expressed in various types of tumors (Grisendi et al., 2006). Thus,
the localization and expression of NPM1 are altered in human
cancers (Grisendi et al., 2006). On the other hand, NPM1.2 which
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RNA binding site, RNase domain, and nucleolar localization signal
of NPM1 (Herrera, Savkur, and Olson, 1995; Hingorani et al.,
2000; Wang et al., 1993) expresses in rat tissue and cells at a low
level in the cytoplasm and nucleoplasm (Wang et al., 1993).
However, the NPM1.2 expression is not found in human normal
cells. Although NPM1.2 expression in human is only detected in
HeLa cells which stably express human papillomavirus (HPV) E6
and E7 proteins (Dalenc et al., 2002; Sautkina et al., 2008), the
function is largely unclear (Herrera et al., 1995; Savkur and Olson,
1998). NPM1 directly interacts with tumor suppressor p14ARF
(ARF) which is an alternative reading frame product of the
p16INK4a locus and antagonizes its function in the nucleoli of
nonstressed cells (Itahana et al., 2003). In response to cellular and
viral stresses, NPM1 is redistributed from the nucleoli to the
nucleoplasm and cytoplasm (Hiscox, 2002; Rubbi and Milner,
2003). There is no evidence that phosphorylation of NPM1 is
involved in its translocation during cellular and viral stresses
(Kurki et al., 2004). Upon cellular stresses, NPM1 binds to HDM2
which inhibits its E3 ubiquitin ligase activity and protects p53
from HDM2-mediated degradation (Kurki et al., 2004). Also,
NPM1 directly interacts with p53 and regulates its protein
stability and transcriptional activity (Colombo et al., 2002). Thus,
NPM1 functions as a critical regulator of ARF, HDM2 and p53 in
the p53 pathway (Grisendi et al., 2006).
Notwithstanding these ﬁndings, the precise biological reasons
why adenoviral pV redistributes NPM1 in vitro and why NPM1 is
redistributed from the nucleoli to the nucleoplasm during infec-
tion are not understood. It is also unclear whether pV induces the
NPM1 redistribution during infection. Here we demonstrate that
pV triggers the relocalization of NPM1 from the nucleoli to the
nucleoplasm in primary human endothelial cells by comparative
analysis using a pV-deletion mutant, Ad5-dV/TSB, of Ad5. We also
provide evidence that adenovirus replication in primary cells
requires the relocalization of NPM1 from the nucleoli to the
nucleoplasm. Moreover, we show that NPM1 knockdown inhibits
Ad5 replication, demonstrating a direct role of NPM1 in adeno-
viral replication. While lack of pV causes a great restriction of
adenoviral replication in primary cells, Ad5-dV/TSB replicates and
induces tumoricidal effect in cancer cells where NPM1 is also
abundant in the nucleoplasm. Additionally, transmission electron
microscope based analysis demonstrates that lack of pV is linked
to a defect in viral assembly in primary cells, but not in cancerous
cells. Furthermore, NPM1 is co-puriﬁed with and can be directly
detected in situ in empty adenovirus particles. Thus, to our
knowledge, NPM1 is the ﬁrst cellular protein to be identiﬁed as
being involved in an event of adenoviral virion maturation. These
ﬁndings imply that at least one signiﬁcant biological function of
pV is in the process of assembly of empty adenovirus particles
during virion maturation, and NPM1 is involved in adenoviral
biology. Also, our data provide an important new insight in
adenoviral assembly and may aid vector design to achieve
the selective replication of adenovirus between normal and
cancer cells.Results
Adenoviral pV is required for NPM1 redistribution from the nucleoli
to the nucleoplasm
We genetically generated the adenoviral mutants except dE1-
dV/TSB which contains both the E1 and pV deletions. A schematic
representation of human adenovirus type 5 (Ad5) and the
mutants used in this study was shown in Supplementary
Fig. S1. Although we previously reported that the Ad5-dV/TSBgenome contains three suppressor mutations in the pre-Mu gene
(Ugai et al., 2007), wild type pre-Mu and mature Mu are not
associated with the NPM1 translocation (Lee et al., 2004). Also,
production of infectious Ad5-dV which is the parental virus of
Ad5-dV/TSB has been dramatically restricted in A549 cells (Ugai
et al., 2007). Thus, we were not able to characterize Ad5-dV in
primary cells. Moreover, we could not generate dE1-dV/TSB in
host cell lines stably expressing E1 proteins, because Ad5-dV/TSB
replication was severely restricted in 293 cells (Fig. S2). Therefore,
we analyzed the pV function by comparing Ad5 with an array of
adenovirus mutants including Ad5-dV/TSB. We ﬁrst investigated
whether adenoviral pV plays a role in translocation of NPM1 from
the nucleoli to the nucleoplasm in human pulmonary endothelial
cells (HPAEC). In our all experiments, we directly ﬁxed cells after
medium was removed as described in Materials and Methods
section, because NPM1 was detected in the nucleoplasm as well
as the nucleoli of HPAEC cells when we washed cells with 30 mM
HEPES-NaOH buffer (pH7.4) (Fig. S3A). Under this condition, we
also detected p53 at the nucleoli in HPAEC cells, but not in cancer
cells (Fig. S3B). Thus, non-activated p53 which exists at very low
levels in normal cells was localized in the nucleoli in normal cells,
although wild type p53 is observed at the nucleus in malignant
cells (Fig. S3B) (Koch et al., 2001). Localization of p53 may result
from two essential regions for nucleolar localization contained in
its C-terminal portion (Karni-Schmidt et al., 2007). Thus, we
examined whether NPM1 is delocalized by adenoviral infection
at an early time point by using Ad5-E3-V-EGFP (Ugai et al., 2010)
containing ﬂuorescently labeled pV (pV-EGFP). Fluorescent signal
for pV-EGFP was detected in Ad5-E3-V-EGFP-infected cells, and
pV-EGFP was colocalized with NPM1 in the nucleoli at 1 h post-
infection (h.p.i.) (Fig. S4A). Also, the partial NPM1 translocation
was detected in an MOI-dependent manner of Ad5-E3-V-EGFP
infection (Fig. S4A). It is unlikely that this translocation of NPM is
a result of adenoviral early proteins expressed from the E1 region,
since NPM1-EGFP expression was predominantly in the nucleoli
of 293-NPM1-EGFP cells which are stably expressing both E1 and
NPM1-EGFP (Fig. S4B). These results, in conjunction with our
published ﬁndings (Hindley et al., 2007; Matthews and Russell,
1998; Ugai et al., 2010), suggested that pV-EGFP released from the
Ad5-E3-V-EGFP particles may move to the nucleoli, and Ad5-E3-
V-EGFP infection induced the NPM1 redistribution at 1 h.p.i.
(Fig. S4A). Indeed, Ad5 infection resulted in the partial disruption
of NPM1 nucleolar localization during the course of infection, but
Ad5-dV/TSB infection did not (Fig. 1). Collectively, these data
indicate that wild type Ad5 infection, but not Ad5-dV/TSB infec-
tion, stimulates the NPM1 redistribution. Also, we conclude that
pV is necessary for NPM1 translocation from the nucleoli during
the course of infection as Ad5-dV/TSB is unable to induce such
changes in contrast to wild type Ad5 (Fig. 1).
Adenoviral pV dictates its viral replication in normal cells
In order to examine whether pV is associated with adenoviral
DNA replication in infected primary cell lines, HUVEC and HPAEC,
we analyzed viral DNA replication by quantifying the copy
number of the E4 region using the E4 primers. These cell lines
express NPM1 at low levels as compared with lung carcinoma
A549 cells (Fig. S5A). Ad5 DNA replication was readily detected in
both primary and A549 cells (Fig. 2A and S5B). By contrast, Ad5-
dV/TSB DNA replication was observed in HPAEC and A549 cells
(Fig. 2A and S5B). Although we observed a severe defect in Ad5-
dV/TSB DNA replication in HUVEC (Fig. 2A), we noted that Ad5
DNA replication was attenuated in HUVEC compared to HPAEC
(Fig. 2A). Therefore, adenoviral DNA replication per se seemed to
be restricted in HUVEC cells. Additionally, lack of pV did not seem
to affect viral DNA replication in infected cells. We also performed
Fig. 1. Adenoviral protein V regulates subcellular localization of NPM1 during infection. HPAEC cells were infected with adenovirus at an MOI of 10 PFU/cell for various
times, followed by immunoﬂuorescent staining. Subcellular localization of adenoviral pV and endogenous NPM1 was observed in infected cells at various times post-
infection. Viral and endogenous cellular proteins in infected cells were visualized by staining with anti-pV and anti-NPM1 followed by secondary antibody conjugated with
ﬂuorescent probes. Uninfected and infected cells were stained for nuclear DNA using Hoechst 33342 and ﬂuorescent signals were visualized by epiﬂuorescence
microscopy.
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Fig. 2. Protein V is required for adenoviral replication in normal cells. (A–C) Primary cells were infected with adenovirus at an MOI of 10 PFU/cell for various times.
(A) Total DNA was extracted from infected cells, and 50 ng of total DNA was analyzed by qPCR. Plots represent as the copy number of the E4 gene per 50 ng of total DNA.
(B) One-step growth curve kinetics of adenoviruses was analyzed in primary cell lines. (C) Proteins were extracted from infected primary cells at various times post-
infection and 40 mg of total proteins were subjected to Western blot with the indicated antibodies. (D) Primary cells were infected with adenovirus at an MOI of 10, 50 or
100 PFU/cell for 1 and 48 h. Crude proteins were extracted from infected cells, and 10 mg of proteins was subjected to Western blot. Ctrl: 1.0109 viral particles (VPs) of
puriﬁed Ad5 were applied as a control for the pV expression. (E) Production level of infectious adenovirus in primary cell lines at 48 h.p.i. was measured by plaque assay.
Results were reported as mean7SD. N.S.; no signiﬁcant difference.
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examine the role of pV in viral replication in primary cells. Ad5
replication was observed in HUVEC and HPAEC cells, but Ad5-dV/
TSB replication was severely restricted in those cell lines (Fig. 2B).
Thus, pV was likely to be associated with viral replication. We
next examined the kinetics of the late viral protein expression in
infected primary cells. The expression of late viral proteins which
were detected by anti-Ad5 antibody was impaired in Ad5-dV/TSB-
infected HUVEC cells as compared to Ad5-infected HUVEC cells(Fig. 2C). In contrast to HUVEC, late viral proteins in both Ad5-
and Ad5-dV/TSB-infected HPAEC cells were similarly expressed
by 24 h.p.i. (Fig. 2C). On the other hand, the onset of the ﬁber
expression was impaired in Ad5-dV/TSB-infected primary cells,
since the expression of ﬁber protein was observed at an early time
point in Ad5-infected primary cells (Fig. 2C). We also conﬁrmed
the lack of pV expression in Ad5-dV/TSB-infected primary cells
(Fig. 2C). Thus, lack of pV affected the expression of ﬁber protein
at an early time point in primary cells (Fig. 2C). Moreover, we
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the viral replication restriction in primary cells. Although over-
expression of late viral proteins was observed in both HUVEC and
HPAEC cells infected with Ad5-dV/TSB at an MOI-dependent
manner (Fig. 2D), Ad5-dV/TSB infection at higher MOIs did not
compensate for the defect in the production of the Ad5-dV/TSB
progeny (Fig. 2E). Further, we examined whether transient
expression of pV affects adenoviral production in primary cells.
Overexpression of pV fused with monomeric red ﬂuorescent
protein 1 (pV-mRFP1) was found to partially induce the NPM1
and p53 redistribution from nucleoli in primary cells compared to
mock-infected cells (Fig. S6A). Both Ad5 and Ad5-dV/TSB produc-
tion was enhanced in primary cells expressing pV (Fig. S6B and C).
This data shows that transiently expressed pV compensates for
the defect in Ad5-dV/TSB replication in normal cells (Fig. S6).
Taken together, these data suggest that pV is essential for
infectious adenovirus particle production in normal cells, but
not adenovirus DNA replication (Fig. 2A, B, E, and S6).
Protein V affects the E1B-55K and pIX expression
We next compared the kinetics of cellular and viral protein
expression in infected primary cells. Ad5 and Ad5-dV-TSB infec-
tions did not affect the expression of NPM1, HDM2, and p53
during the eclipse stage of infection before viral replication, and
ARF which is an alternative reading frame product of the
p16INK4a locus was undetectable in uninfected or infected HPAEC
cells compared to prostate adenocarcinoma DU145 cells which
express low levels of ARF (Fig. S7) (Lee et al., 2005). The lack of
ARF expression in HPAEC cells is consistent with previous data
that ARF expression is not detectable in primary cells (Koch et al.,
2001) and normal tissue (Sherr, 2006). Although ARF is induced
by oncogenic stresses (Sherr, 2006) and stabilizes p53 (Zhang
et al., 1998), we did not observe the ARF expression in infected
HPAEC cells (Fig. S7). Additionally, p53 expression was notFig. 3. Lack of pV affects the E1B-55K and pIX expression. HPAEC cells were infected w
extracted from infected primary cells at various times post-infection and 40 mg of tota
expression of E1b-55k, pIX, and hexon mRNAs. Gene expression levels of E1b-55k, pIX
The data are expressed as the mean values7SD (n¼4). N.S.; no signiﬁcant difference.dramatically changed in both Ad5- and Ad5-dV/TSB-infected cells
(Fig. 3A). The onset of immediate early and early protein expres-
sion was comparable between Ad5- and Ad5-dV/TSB-infected
HPAEC cells, except for the early gene product E1B-55K
(Fig. 3B). Expression levels of the immediate early and early
proteins at each time point were affected by the absence of pV
(Fig. 3B). In particular, the lack of pV showed persisted E1A
expression at 72 h.p.i., and this result was reproductive
(Fig. 3B). Also, the lack of pV was markedly attenuated E1B55K
expression in HPAEC cells (Fig. 3B). Therefore, we examined
mRNA expression level of E1B-55K as well as pIX mRNA by
qRT-PCR, since E1b-55k mRNA shares the polyadenylation signal
with pIX mRNA (Le Moullec et al., 1983). However, lack of pV did
not affect E1B-55K and pIX gene expression in infected primary
cells (Fig. 3C). Furthermore, we tracked pIX expression by mon-
itoring pIX-mRFP1 expression in cells infected with ﬂuorescently
labeled adenoviruses. The pIX-mRFP1 expression was attenuated
in Ad5-wt-IX-mRFP1-infected primary and cancer cells as com-
pared to Ad5-wt-IX-mRFP1-infected cells (Fig. S8). Therefore, this
data also suggested that lack of pV repressed pIX expression in
infected cells (Fig. S8). Although we determined the nucleotide
sequence of the regions for the E1B-55K and the IX genes in the
Ad5-dV/TSB genome, there are no mutations in the regions (data
not shown). Taken together, there data suggested that pV was
associated with the E1B-55K and pIX expression, but not gene
expression of those mRNAs.
Protein V determines the replication property of adenovirus
Lack of E1B-55K mediates a defect in late viral RNA export and
late viral protein expression in primary cells as shown by a study
on the E1B-55K deletion mutant virus, ONYX-015 (dl1520)
(O’Shea et al., 2004). However, dl1520 is an E1b-55K gene
deletion mutant derived from an E3-deleted derivative virus
called dl309 which is a hybrid of Ad2 and Ad5 sequences in theith adenovirus at an MOI of 10 PFU/cell for various times. (A and B) Proteins were
l proteins were subjected to Western blot with the indicated antibodies. (C) Gene
, and hexon mRNAs at various times post-infection were determined by qRT-PCR.
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genetic background compared to the Ad5 genome used in this
study. Therefore, we genetically generated dE1B55K in order to
determine whether restriction of Ad5-dV/TSB replication depends
on reduced expression of E1B-55K. Deletion of the E1B-55K gene
showed a dramatic attenuation of late viral protein expression in
dE1B55K-infected HPAEC as compared to Ad5- and Ad5-dV/TSB-
infected HPAEC cells (Fig. 4A). Despite lack of the E1B-55K
expression and a dramatic attenuation of the late viral protein
expression in dE1B55K-infected HAPEC cells (Fig. 4A), dE1B55K
replication closely paralleled Ad5 replication in HPAEC cells and
had a distinct different proﬁle compared to Ad5-dV/TSB replica-
tion (Fig. 4B). Thus, concomitant reduction of E1B55K expression
observed in Ad5-dV/TSB-infected cells is not directly responsible
for the restriction of Ad5-dV/TSB replication in primary cells.
Although we were able to generate dE1B55K-dV/TSB (i.e., deleted
for E1B-55K and pV shown in Fig. S1), dE1B55K-dV/TSB virus
production was dramatically restricted in A549 cells (see Materi-
als and Methods section). Thus, we were unable to analyze the
growth kinetics and protein expression of dE1B55K-dV/TSB. Also,
we did not detect attenuated expression of late viral proteins in
Ad5-dV/TSB-infected HPAEC cells as similar to that in dE1B55K-
infected HPAEC cells (Fig. 4A). Therefore, the lack of pV does not
seem to completely shut off E1B-55K expression in Ad5-dV/TSB-
infected HPAEC cells. Based on the kinetics of dE1B55K replication
in primary cells (Fig. 4B), we conclude that the attenuation of
E1B-55K is not a major determinant of the replication property of
Ad5-dV/TSB. Collectively, these data illustrate that pV dictates
adenoviral replication in normal cells. Also, these data indicate
that the lack of pV, rather than the E1B-55K status determines
phenotype of Ad5-dV/TSB replication (Fig. 4).Fig. 4. Protein V determines property of adenoviral replication in primary cells.
HPAEC cells were infected with adenovirus at an MOI of 10 PFU/cell for various
times. (A) An equivalent of 40 mg of total proteins was analyzed by Western blot
with the indicated antibodies. (B) One-step growth curve kinetics of adenoviruses
was analyzed in HPAEC cells. Infectious titer was determined by plaque assay.NPM1 promotes adenoviral replication
Analysis of Ad5-dV/TSB-infected cells indicates that pV
induces NPM1 translocation from the nucleoli to the nucleoplasm
(Fig. 1), and transient expression of pV-mRFP1 also triggers NPM1
translocation to the nucleoplasm compared to mock-infected cells
(Fig. S6). Therefore, we tested whether NPM1 knockdown inhibits
adenovirus replication in primary cells. We observed a reduction
of NPM1 mRNA level after NPM1 siRNA treatment (Fig. 5A). Also,
Western blot analysis revealed that NPM1 expression was
reduced in NPM siRNA-transfected cells compared to control
siRNA-transfected cells, but NPM1 knockdown did not alter p53
expression level (Fig. 5B). Immunoﬂuorescence analysis after
NPM1 knockdown showed attenuated NPM1 staining in the
nucleoli, while p53 appeared to be partially translocated from
the nucleoli to the nucleoplasm as compared to the controls
(Fig. 5C). As we expected, NPM1 knockdown dramatically inhib-
ited Ad5 replication compared to control siRNA (Fig. 5D).
However, low levels of Ad5 replication were observed by 48 h.p.i.
in siNPM1-treated HPAEC cells, possibly because adenovirus-asso-
ciated (VA) RNAs inhibit RNAi machinery (Andersson et al., 2005; de
Vries and Berkhout, 2008; Lu and Cullen, 2004; Xu et al., 2007). Also,
NPM1 knockdown did not recover Ad5-dV/TSB replication in
primary cells (Fig. 5D). Therefore, these results indicate that NPM1
is required for adenoviral replication in primary cells.
Ad5-dV/TSB replicates in cancerous cells expressing nucleoplasmic
NPM1
Ad5-dV/TSB replicates well in lung carcinoma A549 cells
which are deleted the gene for ARF and therefore have a defective
p53 pathway (Ugai et al., 2007). In order to understand why pV is
not required for replication in malignant cells, we examined the
expression and localization of NPM1 in cancer cell lines. NPM1
was delocalized in all cancer cell lines assayed, and over
expressed in all cancer cell lines except BXPC-3 when compared
to HPAEC (Fig. S9A and B), conﬁrming previous reports that NPM1
is altered in cancer cells (Grisendi et al., 2006). We further
examined whether Ad5-dV/TSB replicates in a range of cancer
cell lines and observed Ad5-dV/TSB replication in those cancer
cell lines but not in HPAEC cells (Fig. S9C). Also, Ad5-dV/TSB
infection was as effective as Ad5 in inducing cell killing in cancer
cells (Fig. S9D). Moreover, we conﬁrmed that Ad5-dV/TSB produc-
tion was observed in a broad range of cancer cell lines, those
cancer lines containing nucleoplasmic NPM1 (Fig. S9E–G). Collec-
tively, these data showed that in contrast to primary cells, Ad5-
dV/TSB replicates well in a range of cancer cells with readily
detectable nucleoplasmic NPM1.
NPM1 interacts with empty adenovirus particles
Adenoviral protein V is required for NPM1 redistribution from
the nucleoli to the nucleoplasm (Fig. 1), and NPM1 promotes
adenoviral replication (Fig. 5). Therefore, we investigated whether
NPM1 is recruited to adenoviral replication center. We ﬁrst
examined the location of nucleolar NPM1 during infection by
analyzing Ad5-E3-V-EGFP. We tracked ﬂuorescent signals for pV-
EGFP and NPM1 under short time of exposure in order to detect
newly synthesized pV-EGFP in infected primary cells. Therefore,
we did not detect virion-associated pV-EGFP in infected cells at
12 h.p.i., but did detect partial translocation of NPM1 at that time
(Fig. S10A, upper panels for 12 h.p.i.). Newly synthesized pV-EGFP
was detected at the nucleoli in the majority of infected cells by
12 h.p.i. (Fig. S10A and B), and at this time NPM1 was exclusively
associated with pV-EGFP in the nucleoli (Fig. S10A, lower panels
for 12 h.p.i.). At 24 h.p.i., pV-EGFP was translocated from the
Fig. 5. Knockdown of NPM1 inhibits adenoviral replication. (A and B) HPAEC cells were transfected with siRNA for NPM1 mRNA (siNPM1) or a control non-targeting RNA
(siNeg) for 48 h, followed by qRT-PCR to determine knockdown level of NPM1 mRNA (A); Data was shown as mean 7S.E.M., nPo0.01, nnPo0.05; two-tailed unpaired
Student’s t-tests between groups, and Western blot analysis (B). (C) HPAEC cells were transfected with 10 nM siRNA for 48 h, followed by immunoﬂuorescent staining.
(D) One-step growth curve analysis of adenoviruses in siNPM1-treated primary cells. Primary cells transfected with siRNA for 48 h were infected with adenovirus at an
MOI of 10 PFU/cell for various times. Infectious titer was determined by plaque assay.
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ciﬁc nuclear structures; in many cases NPM1 was still restricted
to the nucleolus (Fig. S10A, upper panels for 24 h.p.i.). However,
in other cells at this time point, we observed ﬂecked distribution
of pV-EGFP in the nucleoplasm, and in those cases NPM1 localized
in the nucleoplasmic pV-EGFP-rich centers (Fig. S10A, lower
panels for 24 h.p.i.). The redistribution of pV-EGFP and NPM1
continued during viral replication (Fig. S10A, panel for 36 h.p.i.).
Subsequently, NPM1 was also detected in the cytoplasm at
48 h.p.i. and excluded from the nucleus at 72 h.p.i., while pV-
EGFP was localized in both the nucleus and the cytoplasm
(Fig. S10A). These results agree with a previous report that pV
indirectly induces the NPM1 translocation from the nucleoli to
the nucleoplasm (Matthews, 2001). Although pV-EGFP was
colocalized with NPM1 in the nucleoli and the nucleoplasm
(Fig. S10A), we did not detect this association between pV and
NPM1 in infected HPAEC and 293 cells by immunoprecipitation
analysis (data not shown). We also examined the localization of
NPM1 and pIX-mRFP1 in Ad5-wt-IX-mRFP1-infected HPAEC cells,
and found that NPM1 was partially colocalized with pIX-mRFP1 in
the nucleoplasm of infected HPAEC cells (Fig. S10C). These data
indicate that a proportion of NPM1 is present in the same
location, as both capsid (pIX) and core (pV) structural proteinsaccumulate in the nucleoplasm (Fig. S10A and C). Collectively,
these data imply that nucleoplasmic NPM1 may play a role in
adenoviral assembly. Adenoviral mature virions are produced
through three intermediates during maturation: empty virus
particles, incomplete virus particles, and young virions
(Edvardsson et al., 1976; Ishibashi and Maizel, 1974). Protein V
is included in young and mature virions, but not empty virus
particles and incomplete virus particles (Ishibashi and Maizel,
1974). Our ﬁndings prompted us to investigate by transmission
electron microscope (TEM) whether assembled Ad5-dV/TSB par-
ticles are detected in infected primary cells. While wild type Ad5
particles were readily detected in infected primary cells, the Ad5-
dV/TSB particles were not (Fig. 6A). In contrast to primary cells,
both wild type Ad5 and Ad5-dV/TSB particles were readily
observed in infected A549 cells (Fig. 6A). Thus, TEM analysis
showed that Ad5-dV/TSB was defective for assembly in primary
cells (Fig. 6A). Because we could not detect Ad5-dV/TSB particles
in infected HPAEC cells (Fig. 6A), we next examined whether
NPM1 plays a role during viral assembly. Therefore, we puriﬁed
empty and infectious virus particles from the nuclei of infected
A549 cells (Fig. 6B and C) and analyzed whether NPM1 is
contained in the fraction of those virus particles. Western blot
analysis showed NPM1 was co-fractionated with empty virus
Fig. 6. NPM1 is involved in empty adenovirus particles. (A) HPAEC and A549 cells were infected with adenovirus at an MOI of 10 PFU/cell, followed by cell harvesting at
72 h.p.i. Uninfected and infected cells were ﬁxed in 30 mM HEPES-NaOH buffer (pH 7.4) containing 1.25% glutaraldehyde and 2% paraformaldehyde, embedded, and
sectioned for transmission electron microscopy. (i–iv) White framed areas display enlarged areas. (B) Analysis of protein composition of viral particles by GELCODE blue
staining. Infectious and empty virus particles (VPs) of Ad5 were CsCl-puriﬁed from the nuclei fraction of infected A549 cells. A total of 1.01010 VPs of puriﬁed infectious
and empty VPs was separated by electrophoresis in 10% SDS-PAGE, and the gel was stained with GELCODE Blue Stain Reagent. (C) Validation of puriﬁed infectious and
empty VPs by PCR analysis. The ﬁber gene was ampliﬁed using a template which is equivalent to 1.01010 VPs of puriﬁed VPs. (D) Detection of NPM1 in the fraction of the
Ad5 empty VPs. Infectious and empty VPs were denatured and separated by electrophoresis in 10% SDS-PAGE, followed by Western blot analysis using indicated
antibodies. An equivalent of 10 mg total proteins which were extracted from A549 cells was applied for a control to detect cellular proteins. (E) Immunoelectron
microscopic analysis of NPM1 accessibility on empty VPs. To test the accessibility of NPM1 on empty VPs, infectious and empty VPs were bound on copper grids with a
carbon-coated Formvar ﬁlm. The NPM1 epitope was detected with indicated antibodies, followed by donkey anti-mouse immunoglobulin conjugated with 10-nm gold and
donkey anti-rabbit immunoglobulin conjugated with 25-nm gold. Electron micrographs for the adenoviral particles were taken with JEOL 1200 EX II Transmission Electron
Microscope.
H. Ugai et al. / Virology 432 (2012) 283–295290particles (Fig. 6D), and immunoelectron microscopic analysis
demonstrated that NPM1 is detected around empty virus parti-
cles, but not infectious virus particles (Fig. 6E). Taken together,
our data suggest that pV is essential for viral assembly in normal
cells, but not cancer cells, and that NPM1 interacts with empty
virus particles and may be involved in a process of virion
maturation.Discussion
In response to cellular stress, p53 is rapidly stabilized and
activated by posttranslational modiﬁcation at serines 15 and 20
mediated through ATM and CHK2, respectively, and CHK2 is itself
activated by ATM (Toledo and Wahl, 2006). However, adenoviral
proteins such as the E1B-55K/E4ORF6 complex not only degrade
p53 (Querido et al., 1997) but also block signaling through degrada-
tion of the MRN (Mre11/RAD50/NBS1) complex (Carson et al., 2003)
which activates ATM (Lee and Paull, 2005). Also, E1A and E4ORF3
inactivates p53-mediated transactivation (Somasundaram and El-
Deiry, 1997) and p53 independently of E1B-55K by preventing p53-
DNA binding (Soria et al., 2010), respectively. Thus, degradation of
p53 (Querido et al., 1997) and elimination of p53 activity (Soriaet al., 2010) are considered essential to maximize adenoviral
replication (Levine, 2009). Although adenovirus utilizes the p53
pathway for infection (Sherr and McCormick, 2002), p53 is not
stabilized, and its target genes are not activated throughout wild
type adenoviral infection (Soria et al., 2010). Therefore, adenoviral
mutants which are incapable of antagonizing p53 and/or its activity
were considered to be useful for cancer gene therapy (Bischoff et al.,
1996; Soria et al., 2010). However, there is no direct proof that p53
and/or its activity inhibit wild type adenoviral replication (Koch
et al., 2001). Importantly, adenoviral replication observed by virion
maturation is clearly detected in p53-negative cells (Harada and
Berk, 1999), and adenoviral assembly does not require p53 and its
activity (Koch et al., 2001; Levine, 2009). Thus, adenoviral assembly
occurs independently of p53 and its activity (Harada and Berk, 1999;
Koch et al., 2001; Levine, 2009).
Adenovirus interacts with and disrupts host nucleoli during
viral lytic growth (Lam et al., 2009; Lawrence et al., 2006) and
disrupts NPM1 nucleolar localization (Matthews, 2001; Walton
et al., 1989). Thus, adenovirus infection reorganizes nucleolar
NPM1 for productive infection. Our comparative experiments
with Ad5-dV/TSB revealed that pV is essential for disrupting the
delocalization of nucleolar NPM1 during infection (Fig. 1), and
this redistribution of NPM1 was correlated with adenoviral
H. Ugai et al. / Virology 432 (2012) 283–295 291replication (Figs. 1, 2, 4, and S10). Also, our result revealed that
the pV translocation from the nucleoli to the nucleoplasm coin-
cided with the delocalization of nucleolar NPM1 during infection
(Fig. 1 and S10). Therefore, NPM1 is considered to be associated
with adenoviral replication.
NPM1 colocalizes with pre-terminal protein (pTP) and DNA-
binding protein (DBP) involved in adenoviral DNA replication
during infection (Hindley et al., 2007), and a cellular fraction
containing NPM1 which was puriﬁed from HeLa cells stably
expressing HPV E6 and E7 proteins stimulates adenoviral DNA
replication in vitro (Okuwaki et al., 2001). Although NPM1
appeared to associate with adenoviral DNA replication, recombi-
nant protein NPM1 did not enhance adenoviral DNA replication
in vitro (Okuwaki et al., 2001). On the other hand, HPV E6 and E7
proteins enhance adenoviral DNA replication in vitro and in vivo
(Steinwaerder et al., 2001). Therefore, the contribution of NPM1
to enhancement of adenoviral DNA replication observed in vitro
still remains to be elucidated. Importantly, NPM1 seemed to be
dispensable for adenoviral DNA replication, because Ad5-dV/TSB
DNA replication was observed at an absence of nucleoplasmic
NPM1 in infected HPAEC cells (Figs. 1 and 3A). In our result, NPM1
knockdown showed that it promoted adenoviral replication
(Fig. 4), suggesting an involvement of NPM1 in a process of
adenoviral replication. Although NPM1 phosphorylation, involved
in its relocalization in response to cellular and viral stresses, is not
observed (Kurki et al., 2004), signiﬁcantly, we have identiﬁed a
viral factor, pV, to trigger the NPM1 delocalization in infected
normal cells by comparing with Ad5-dV/TSB.
Adenoviral E1A gene products activate the E1b promoter
(Imperiale et al., 1983) as well as other early promoters (Nevins,
1987). Since E1A was abundantly expressed in Ad5-dV/TSB-
infected primary cells by 24 h.p.i. (Fig. 3B), it seems to activate
the E1b promoter. NPM1 is selectively and speciﬁcally deposited
on E1b mRNA during its 3’-end processing in vitro (Palaniswamy
et al., 2006), and a reduction of NPM1 expression by knockdown
causes accumulation of E1b mRNA in the nucleus in vitro (Sagawa
et al., 2011). Accordingly, an absence of NPM1 observed in the
nucleoplasm of Ad5-dV/TSB-infected primary cells (Fig. 1) seems
to result in accumulation of E1b-55k and pIX mRNAs in the
nucleoplasm. Thus, we might detect attenuated expression of
E1B-55K and pIX-mRFP1 in Ad5-dV/TSB-infected cells (Figs. 3B
and 4A, and S8).
We have previously reported that pIX was similarly incorpo-
rated in puriﬁed Ad5-dV/TSB as well as puriﬁed Ad5 (Ugai et al.,
2007). The pIX gene is deleted from the Ad5 genome and the lack
of pIX does not affect its viral replication (Sargent et al., 2004).
On the other hand, our experiments with several adenoviral
mutants revealed that attenuation of the E1B-55K expression
mediated by lack of pV is not responsible for the Ad5-dV/TSB
replication in primary cells (Fig. 3). Attenuation of the E1B-55K
expression may induce p53 stabilization in Ad5-dV/TSB-infected
primary cells as observed in dl1520-infected primary cells
(O’Shea et al., 2004), and p53 stabilization may suppress Ad5-
dV/TSB replication. However, active and non-degradable p53 does
not inhibit adenoviral replication (Koch et al., 2001) and over-
expression of p53 mediated by a p53-recombinant adenovirus
does not impair its production (Sauthoff et al., 2002). Therefore,
p53 stabilization does not seem to restrict Ad5-dV/TSB replication
in primary cells. Collectively, lack of pV, but not p53 stabilization,
E1B-55K and pIX attenuation, resulted in restriction of Ad5-dV/
TSB replication in primary cells.
NPM1 is apparently localized to the nucleoplasm during infec-
tion (Hindley et al., 2007; Walton et al., 1989) and is likely to be
relocalized from the nucleoli to the nuclear matrix to form pseudo-
nucleoli (Walton et al., 1989) nucleated around adenoviral genomes
(Bodnar et al., 1989; Schaack et al., 1990), mRNA (Gallinaro et al.,1983), and proteins (Hindley et al., 2007). We also observed that
NPM1 was reorganized from the nucleoli to the nucleoplasm and
colocalized with capsid and core proteins, pIX and pV, during
productive infection (Fig. 1, S10A and C). Therefore, our results
suggested that NPM1 was involved in an event of adenoviral
assembly. The average molecular mass of empty adenovirus parti-
cles is approximately 123 MDa (Tibbetts and Giam, 1979). On the
other hand, NPM1 is present as monomeric and hexameric forms in
cells, and the molecular weights of those forms are approximately
37 kDa and 230 kDa, respectively (Yung and Chan, 1987). The
sedimentation rates (550-650S) of adenoviral intermediates are
different from that (10S) of NPM1 puriﬁed from cells (Ostapchuk
and Hearing, 2005; Yung and Chan, 1987). Thus, our data demon-
strated that NPM1 is co-puriﬁed with empty adenovirus particles
from infected cells and speciﬁcally interacts with empty adenovirus
particles (Fig. 6D and E). To our knowledge, NPM1 is the ﬁrst cellular
protein shown to be integrated into empty adenovirus particles. We
detected the Ad5-dV/TSB viral particles in infected cancer cells, but
did not detect them in infected HPAEC cells (Fig. 6A). Also, NPM1
knockdown inhibited production of infectious Ad5 progeny (Fig. 5D).
Therefore, our data suggest that NPM1 is required for promoting
assembly of capsid proteins. Additionally, our results suggested that
NPM1 was released from infectious viral particles after virion
maturation, because it was not incorporated in puriﬁed infectious
viral particles (Fig. 6D and E). Therefore, NPM1 seems to play a role
in capsid formation during virion maturation.
Our study is the ﬁrst to show that adenoviral minor core
protein V mediates the NPM1 translocation from the nucleoli to
the nucleoplasm during productive infection in normal cells and
that this event is required for productive infection in normal cells.
Moreover, we propose that as infection progresses a pV-mediated
NPM1 redistribution is associated with capsid formation during
virion maturation. Therefore, the pV-mediated build-up of
nucleoplasmic NPM1 is essential for adenoviral replication in
normal cells. Also, lack of pV seems to function as a novel
determinant for the selective replication between cancer and
normal cells. Our data shows that pV-deleted adenoviruses may
offer a novel approach to the development of oncolytic adeno-
viruses for cancer therapy that is distinct from current approaches
through E1A and E1B-55K.Materials and methods
Cells
Human embryonic retinoblast cell line 911 was a kind gift of
Dr. Alex J. van der Eb (Leiden University, Leiden, the Netherlands).
Human umbilical vein endothelial cells (HUVEC) and pulmonary
artery endothelial cells (HPAEC) were purchased from Lonza
Walkersville, Inc. (Walkersville, MD). The other cell lines were
obtained from American Type Culture Collection (ATCC; Rockville,
MD). The 293 cells stably expressing human NPM1-EGFP (293-
NPM1-EGFP) were generated with plasmid pEGFP-N1-NPM1
(Hindley et al., 2007) and selected with 1 mg/ml geneticin
(G418). All cell lines were cultured with media recommended
by the depositor. Information of human cell lines used in this
study was provided in Supplementary Table 1.
Adenoviruses
Ad5 (Ugai et al., 2007), Ad5-dV/TSB (Ugai et al., 2007), Ad5-wt-IX-
mRFP1 (Le et al., 2006a), and Ad5-E3-V-EGFP (Le et al., 2006b) were
previously reported. Adenoviral mutants, Ad5-dV/TSB, dE1B55K, and
dE1B55K-dV/TSB, were generated from pTG3602-dV/TSB, pTG3602-
dE1B55K, and pTG3602-dE1B55K-dV/TSB, respectively, as described
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which contains the deletion of both the E1 region and pV gene was
not generated using pTG3602DS-dE1-dV/TSB. dE1B55K is an adeno-
virus mutant containing a deletion of the E1b-55k gene, and
dE1B55K-dV/TSB is an adenovirus mutant carrying both the
E1b-55k and the pV gene deletions. Ad5-dV/TSB-IX-mRFP1 which
is a ﬂuorescently labeled Ad5-dV/TSB was generated by the DNA-
TPC method as described in Supplementary Information. The
particles and infectious titers of adenoviruses used in this study
were: Ad5 (4.941011 VP/ml and 1.581010 PFU/ml), Ad5-dV/TSB
(4.351012 VP/ml and 2.331010 PFU/ml), Ad5-wt-IX-mRFP1
(2.091012 VP/ml and 2.17109 PFU/ml), Ad5-E3-V-EGFP (5.71
1011 VP/ml and 1.031010 PFU/ml), dE1B55K (2.941012 VP/ml
and 1.521010 PFU/ml), dE1B55K-dV/TSB (1.971012 VP/ml and
8.42106 PFU/ml), and Ad5-dV/TSB-IX-mRFP1 (1.821012 VP/ml
and 1.671010 PFU/ml).
Determination of protein concentration
Total protein concentration of cell lysates extracted from
uninfected and adenoviral infected cells was determined using
DC protein assay kit (Bio-Rad laboratories Inc.) according to the
manufacturer’s instructions.
Antibodies
The primary antibodies were used against adenoviral pV
[1:1000, rabbit polyclonal (Matthews and Russell, 1998)], Ad5
[1:1000, rabbit polyclonal anti-serum (Ugai et al., 2007) for
Western blot analysis and 1:20 for immunoelectron microscopy],
E1A (M58 at 1:200, mouse monoclonal, Calbiochem, San Diego,
CA), E1B-55K (1:10, mouse monoclonal 2A6, from A. J. Levine, The
Cancer Institute of New Jersey), E2A (1:10, mouse monoclonal B6,
from A. J. Levine, The Cancer Institute of New Jersey), E3-ADP
(1:500, rabbit polyclonal anti-ADP peptide antibodies p63-77,
from W. S. M. Wold, St. Louis University), E4orf6, 6/7 (1:10,
RSA-3, from T. Shenk, Princeton University). Also, we used p53
antibody (DO-1 at 1:200; Santa Cruz Technology Inc., Santa Cruz,
CA) and HDM2 (SMP14 at 1:200; Santa Cruz Technology Inc.,
2A10 at 1:100; Abcam Inc., Cambridge, MA), ARF (C-18 at 1:200;
Santa Cruz Technology Inc., 4C6/4 at 1:1000; Abcam Inc.), b-actin
(AC-15 at 1:1000; Abcam Inc.), and NPM1 (FC-61991 at 1:1000 for
Western blot analysis and 1:20 for immunoelectron microscopy).
Western blot analysis, immunoprecipitation, and gel-staining
analyses
Cells were cultured on 6-well plates and 15-cm dishes,
respectively, for 2 day, and the number of cells was counted to
determine a multiplicity of infection (MOI). Cells were infected
with adenovirus at an MOI of 10 PFU/cell, or at MOIs speciﬁed in
the Figure legend. The infected cells and the medium were
harvested by using a cell lifter at various time points post-
infection. The cell suspension was centrifuged at 1000 g for
5 min at 4 1C to remove medium. Infected cells were resuspended
with 5 ml of phosphate-buffered saline (PBS) or 30 mM HEPES-
buffered saline, and centrifuged at 1000 g for 5 min at 4 1C. The
infected cancer and HPAEC cell pellets were resuspended with
100 ml and 400 ml of lysis buffer (30 mM HEPES-NaOH [pH 7.4],
1% Nonidet P-40, 0.5 mM EDTA, 150 mM NaCl) containing pro-
tease inhibitor (Sigma–Aldrich, St. Louis, MO), respectively. The
cell lysate was centrifuged at 15,000 g for 5 min at 4 1C to
remove cell debris, and the supernatant was stored at 80 1C
prior to Western blot analysis. Cell lysates extracted from adeno-
virus infected cells were separated by 10% (w/v) SDS-polyacryla-
mide gel electrophoresis (SDS-PAGE). Immunoprecipitation and/or Western blot analysis was carried out as described elsewhere
(Fukuda et al., 2003; Ugai et al., 2005), and the signals were
visualized by enhanced chemiluminescence (Amersham, Piscat-
away, NJ). Also, puriﬁed viral particles were analyzed by using
GELCODE Blue reagent (Pierce Biotechnology Inc., Rockford IL).
Pre-stained protein ladder of Kaleidoscope Standards (Bio-Rad
Laboratories, Inc., Hercules, CA) was used.
Tracking of cellular and viral proteins
An equivalent of 1.0104 cells was cultured on a collagen
coated glass bottom dish (World Precision Instruments, Inc.,
Sarasota, FL) for 24 h. For the tracking of ﬂuorescently labeled
adenovirus at the early stage of viral infection, HPAEC cells were
infected by ﬂuorescently labeled adenoviruses at an MOI of 10,
100 or 1000 PFU/cell and the infected cells were incubated at
37 1C for 1 h. Also, localization of cellular proteins in primary and
cancer cell lines was veriﬁed by immunoﬂuorescence staining. In
order to observe localization of cellular and viral proteins at
various time points in infected cells, cells were infected with
adenovirus at an MOI of 10 PFU/cell, and localization of cellular
and viral proteins was veriﬁed by immunoﬂuorescence staining.
Immunoﬂuorescence
Cells were cultured on a collagen coated glass bottom dish
(World Precision Instruments, Inc., Sarasota, FL) for 24 h. We ﬁrst
optimized immunoﬂuorescence staining in cells and performed
the staining procedure without a washing step with 1 ml of
30 mM HEPES-NaOH buffer (pH 7.4) before the ﬁxation step.
Because the release of nucleolar proteins from the nucleoli of
primary cells was detected, we skipped the washing step for
immunoﬂuorescence staining. In brief, after growth medium was
removed, cells were directly ﬁxed with 1 ml of 30 mM HEPES-
NaOH buffer (pH 7.4) containing 0.01% of glutaraldehyde and 2%
paraformaldehyde for 10 min. After remove the ﬁxative solution,
the cells were two times washed with 1 ml of 30 mM HEPES-
NaOH buffer (pH 7.4) and permeabilized with 1 ml of 30 mM
HEPES-NaOH (pH 7.4) containing 1% Triton X-100 for 30 s. The
cells were two times washed with 1 ml of 30 mM HEPES-NaOH
buffer (pH 7.4) and incubated with 1 ml of blocking solution
(30 mM HEPES-NaOH buffer [pH 7.4], 2% FBS, and 0.2 M glycine)
for 10 min. The cells were two times washed with 1 ml of 30 mM
HEPES-NaOH buffer (pH 7.4) and incubated with a primary
antibody for 1 h at room temperature. The cells were two times
washed with 1 ml of 30 mM HEPES-NaOH buffer (pH 7.4) and
incubated with a second antibody conjugated with Alexa Fluor
488 or Alexa Fluor 594 (dilution range 1: 1000–10,000) for
overnight under dark condition. The cells were four times washed
with 1 ml of 30 mM HEPES-NaOH buffer (pH 7.4) for 10 min each.
DNA was stained with 1 ml of 30 mM HEPES-NaOH buffer (pH
7.4) containing 0.2 mg/ml Hoechst 33342 (Sigma–Aldrich), and
the cells were four times washed with 1 ml of 30 mM HEPES-
NaOH buffer (pH 7.4) for 10 min each. The ﬂuorescent signals
were detected by ﬂuorescence microscopy.
siRNA
The siRNA duplexes for p53, and NPM1 mRNA sequences and
non-silencing which are commercially available and had been vali-
dated were purchased from Qiagen Inc., Valencia, CA. The p53 siRNA
duplex sequences are 50-AGGUGGUUCUCUUCCCAAATT-30 (sense
strand) and 50 0-UUUGGGAAGAGAACCACCUTT-30 (antisense strand),
and the NPM1 siRNA duplex sequences are 50-GGAAAUUUGCGU-
GUGGAGUTT-30 (sense strand), 50-ACUCCACACGCAAAUUUCCTT-30
(antisense strand). AllStars negative control siRNA was used for
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at a density of 1.0104 cells per dish on a collagen coated glass
bottom dish or 6-well plate for 24 h. Transfection was performed
with Lipofection 2000 according to the manufacturer’s instructions, at
a ﬁnal concentration of 5 nM or 10 nM siRNA for 48 h. The trans-
fected cells were used for immunoﬂuorescence or adenoviral
infection.
PCR and quantitative PCR analyses
Adenoviral genome was extracted from puriﬁed infectious
viral particles and capsid complex by method described pre-
viously (Saito et al., 1985), and an equivalent of 1.01010 viral
particles was used for template of PCR ampliﬁcation with
FIBF31136 (50-CCCAATGGGTTTCAAGAGAGT-30) and FIBR32843
(50-ATGACTTGAAATTTTCTGCAATTG-30). PCR was performed by
using KOD Hot Start Master Mix (EMD Millipore, Darmstadt,
Germany) according to the manufacturer’s instructions. Cells
were grown to 80% conﬂuency in 6-well plate and the number
of cells in a dish was counted before viral infection. We infected
cells with adenovirus at an MOI of 10 PFU/cell and maintained
infected cells in 3 ml of medium. The infected cells were
harvested at various times post-infection by using a cell scraper.
Total cell DNA containing the adenoviral genome was extracted
by method described previously (Saito et al., 1985) and stored at
80 1C prior to quantitative PCR (qPCR) analysis. Oligonucleo-
tides corresponding to the sense strand of adenoviral E4 region
(50-TGACACGCATACTCGGAGCTA-30: 34,885–34,905 nucleotide
position [nt]), the antisense strand of the E4 region (50-TTTGAG-
CAGCACCTTGCATT-30: 34,977–34,958 nt), and a TaqMan probe
(50-FAM-CGCCGCCCATGCAACAAGCTT-BHQ-1-30: 34,930–34,951 nt)
were synthesized and used as PCR primers and TaqMan probe for
qPCR. The qPCR conditions were as follows: 35 cycles of denatura-
tion (94 1C, 20 s), annealing (55 1C, 20 s), and extension (72 1C, 30 s).
The Ad5 genome was used to generate a standard curve for the
adenoviral E4 DNA copy number. Three replicates were performed
with 50 ng of total DNA extracted from infected cells and control
sample without template. To determine lentiviral titer, (Delenda
and Gaillard, 2005; Sastry et al., 2002) we used a primer set;
2875–2893F (50-GCCGTCTTTTGGCAATGTG-30) and 2921–2940R
(50-CCCCTAGGAATGCTCGTCAA-30), and FastStart SYBR Green master
(Roche Applied Science, Mannheim, Germany).
Quantitative RT-PCR analysis
Total RNA was extracted from infected cells using Trizol reagent
according to manufacturer’s instructions (Invitrogen, Carlsbad, CA)
and incubated DNase (Promega Corporation, Madison, WI)
to resolve host and viral DNA. DNase was inactivated and removed
by phenol/chloroform extraction. Quantitative RT-PCR (qRT-PCR) was
performed using the following primers designed by Primer 3
(http://frodo.wi.mit.edu/primer3/); NPM1F; 50-TCTCTTCCCAAAGTGG




and TPL-3rd-RT-PCR; TAACCAGTCACAGTCGCAAG. Each reaction for
qRT-PCR was performed with 100 ng of total RNA and control sample
without template, and Brilliant SYBER Green QRT-PCR Master mix
was utilized according to the manufacturer’s protocol (Strategene, La
Jolla, CA). The following qRT-PCR condition applied: 30 min at 50 1C
for reverse transcription, 1 min at 95 1C for denaturation reaction, and
45 cycles of 15 s at 95 1C, and 30 s at 72 1C for analyzing gene
expression of NPM1 and hexon, and 45 cycles of 15 s at 95 1C and
1min at 60 1C for analyzing gene expression of E1b-55k and pIX.
Analysis of qRT-PCR was performed by 2DDCT method after thethreshold cycle (CT) of each sample was normalized to the intrinsic
control (GAPDH). For the detection of GAPDH gene expression, the
following primers were used: GAPDHF; 50-GGTTTACATGTTCCAATAT-
GATTCCA-30, GAPDHR; 50-ATGGGATTTCCATTGATGACAAG-30, and a
TaqMan probe; 50-HEX-CGTTCTCAGCCTTGACGGTGCCAT-BHQ-1-30.
Immunoelectron microscopy and transmission electron microscopy
(TEM)
A total of 1.0108 VP equivalents of puriﬁed viral particles
were transferred into a 1.5-ml tube and vortexed for 20 s (sec) to
break up aggregates. The ﬁrst antibody was added the viral
solution and stored at room temperature for 1 h. Ten microliters
of the solution were placed on paraﬁlm, and a glow discharged
grid (400-mesh, pure carbon support ﬁlms; Electron Microscopy
Sciences, Hatﬁeld, PA) was placed on the viral solution for 1 h. The
carbon grids were washed for 30 s with 100 ml of ﬁltered 30 mM
HEPES-NaOH buffer (pH 7.4) on paraﬁlm ten times at room
temperature, and blocked two times with 1% bovine serum
albumin (BSA; Sigma–Aldrich) in 30 mM HEPES-NaOH buffer
(pH 7.4) at room temperature for 20 min. Subsequently, the
carbon grids were incubated with donkey anti-mouse IgG anti-
body conjugated with 10-nm gold (1:40) or donkey anti-rabbit
IgG antibody conjugated with 25-nm gold (1:40) at room tem-
perature for 1 h. Next, the grids were washed for 30 s on paraﬁlm
three times with 1% BSA in 30 mM HEPES-NaOH buffer (pH 7.4) at
room temperature. The viral particles were ﬁxed with 100 ml of
1% glutaraldehyde in 30 mM HEPES-NaOH buffer (pH 7.4) for 20 s
at room temperature, and the grids were washed for 30 s three
times with 100 ml of 30 mM HEPES-NaOH buffer (pH 7.4). The
adenoviral particles on the grid were negatively stained with 1%
(wt/vol) uranyl acetate at room temperature for 10 s and, subse-
quently, the grids were air dried. Electron micrographs for the
adenoviral particles were taken with FEI Tecnai F20 200 kV at the
High-Resolution Imaging Facility in the University of Alabama at
Birmingham and Molecular Microbiology Imaging Facility at
Washington University in St. Louis. Also, we analyzed infected
cells by TEM. In brief, cells cultured in 15-cm dish were infected
with adenovirus at an MOI of 10 PFU/cell, and infected cells were
incubated for 72 h. Infected cells were harvested according to the
manufacturer’s (Lonza Walkersville, Inc.) instructions. The har-
vested cells were ﬁxed with a ﬁxative solution (30 mM HEPES-
NaOH buffer [pH 7.4] containing 1.25% of glutaraldehyde and 2%
paraformaldehyde) for 1 h at room temperature. The ﬁxed cells
were centrifuged at 1000 g for 5 min at room temperature and
resuspended with the ﬁxative solution. TEM was performed at
School of Veterinary Medicine Microscopy Center in Louisiana
State University.
Statistical analysis
Statistical analysis was performed with two-tailed unpaired
Student’s t-tests between groups (nPo0.01, nnPo0.05, N.S. no
signiﬁcant difference).
Additional materials and methods
Additional materials and methods and any associated refer-
ences were described as supplemental materials and methods.Acknowledgments
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